Upregulation of miR-32 in tissue and plasma and its association with PTEN expression in colorectal cancer
Bayan Mehrjoei, Susan Tahmasebi, Lida Haghnazari, Parmida Rezvani, Homayoon Bashiri, Nayebali Rezvani · 2026
Read Upregulation of miR-32 in tissue and plasma and its association with PTEN expression in colorectal cancer by Bayan Mehrjoei, Susan Tahmasebi, Lida Haghnazari, Parmida Rezvani, Homayoon Bashiri, Nayebali Rezvani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471249.txt.
Description
Mehrjoei and colleagues tested a tiny RNA regulator, miR-32, as a blood signal for colorectal cancer in 2026, where early detection transforms outcomes. The team measured PTEN, the target gene of miR-32, alongside the RNA itself in tumor tissue, nearby healthy tissue, and blood plasma. Samples came from 55 patients and 55 matched controls, and statistical curves judged how well the marker separates the groups.
The pattern was clean and mirrored: miR-32 ran significantly high in both tumors and plasma. PTEN, a tumor suppressor the RNA helps silence, ran low in tumors, the two moving in opposite directions as biology predicts. As a diagnostic test, tissue miR-32 scored 0.94 accuracy on a scale where 1.0 is perfect, and plasma scored a still-good level near the mid-eighties in percentage terms. Higher miR-32 also tracked with more advanced tumor stage. The authors propose it as a non-invasive detection candidate, pending larger validation.
Catalog record
| CREATOR | Bayan Mehrjoei, Susan Tahmasebi, Lida Haghnazari, Parmida Rezvani, Homayoon Bashiri, Nayebali Rezvani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |